All reports
All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
Specific domain:
- Cancer (1) Apply Cancer filter
- (-) Remove Drugs filter Drugs (10)
- Endocrine diseases, diabetes and liver diseases (2) Apply Endocrine diseases, diabetes and liver diseases filter
- Geriatrics and chronic diseases (1) Apply Geriatrics and chronic diseases filter
- Infectious diseases (3) Apply Infectious diseases filter
- Neurology and brain disease (1) Apply Neurology and brain disease filter
-
[Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]
KCE Reports 157 (2011)
-
Antiviral agents in seasonal and pandemic influenza. Literature study and development of practice guidelines
KCE Reports 49 (2006)
-
Barriers and opportunities for the uptake of biosimilar medicines in Belgium
KCE Reports 199 (2013)
-
Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study
KCE Reports 127 (2010)
-
Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C
KCE Reports 276 (2016)
-
Future scenarios about drug development and drug pricing
KCE Reports 271 (2016)
-
Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment
KCE Reports 111 (2009)
-
Publicly funded Practice-oriented Clinical Trials
KCE Reports 246 (2015)
-
Towards a better managed off-label use of drugs
KCE Reports 252 (2015)
-
Trastuzumab in Early Stage Breast Cancer
KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)